Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Direct Second Autologous Stem Cell Transplantation Versus Re-Induction Followed by Transplantation in Relapsed Multiple Myeloma: A Multicenter Real-World Study.

Journal of clinical medicine·2026
Same author

Distribution of HFE Gene Variants in Patients Undergoing Genetic Testing in Türkiye: A Retrospective Analysis of 643 Cases.

The Eurasian journal of medicine·2026
Same author

Clinicopathological features of adult lymphoblastic lymphoma: a retrospective multicenter study from Türkiye.

Frontiers in oncology·2026
Same author

Is Unidentified Cytopenia Truly Unidentified? Or Are We Overlooking Clonality?

Medicina (Kaunas, Lithuania)·2026
Same author

Analytical Performance and Inter-Method Agreement of a Laboratory-Developed CMV qPCR Assay in Clinical Plasma Samples.

Microorganisms·2026
Same author

Clinical Associations of Osteoporosis in BCR::ABL1 Negative Myeloproliferative Neoplasms.

International journal of endocrinology·2026

Related Experiment Video

Updated: Oct 2, 2025

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.2K

A novel differential diagnosis algorithm for chronic lymphocytic leukemia using immunophenotyping with flow

Zehra Narli Ozdemir1, Mesude Falay2, Ayhan Parmaksiz3

  • 1Ankara City Hospital, Ankara, Turkey.

Hematology, Transfusion and Cell Therapy
|February 26, 2022
PubMed
Summary

A new algorithm using flow cytometry improves chronic lymphocytic leukemia (CLL) diagnosis. This method accurately distinguishes CLL from other lymphoproliferative disorders (LPDs) using key markers.

Keywords:
Chronic lymphocytic leukemiaFlow cytometryHierarchical logistic regression model

More Related Videos

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

13.8K
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.7K

Related Experiment Videos

Last Updated: Oct 2, 2025

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

14.2K
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
10:18

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

13.8K
Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.7K

Area of Science:

  • Hematology
  • Immunophenotyping
  • Flow Cytometry

Background:

  • Accurate diagnosis of chronic lymphocytic leukemia (CLL) is crucial, especially in ambiguous cases.
  • Immunophenotyping via flow cytometry is a key diagnostic tool.
  • A clinical decision algorithm can enhance diagnostic accuracy for CLL.

Purpose of the Study:

  • To develop a novel differential diagnosis algorithm for CLL using flow cytometry immunophenotyping.
  • To improve the accuracy of CLL diagnosis and differentiation from other lymphoproliferative disorders (LPDs).

Main Methods:

  • Utilized a hierarchical logistic regression model (Backward LR) to construct a predictive algorithm.
  • Included 302 patients: 220 with CLL and 82 with other B-cell LPDs.
  • Analyzed specific immunophenotypic markers including CD5, CD43, CD81, ROR1, CD23, CD79b, FMC7, sIg, and CD200.

Main Results:

  • The Backward LR model identified CD5, CD23, CD200, and CD81 as significant variables.
  • Increased expression of CD5, CD23, and CD200, and weak CD81 expression, correlated with CLL diagnosis (p < 0.05).
  • The algorithm achieved 95.27% sensitivity and 91.46% specificity, with an overall correctness rate of 95.7%.

Conclusions:

  • A novel diagnostic algorithm utilizing four key markers (CD81, CD5, CD23, CD200) was developed.
  • The algorithm demonstrates high sensitivity and specificity for CLL diagnosis.
  • This tool effectively distinguishes CLL from other LPDs.